Search

everythinglearnresearchcommunity

for

Search:↓

Microneedling improves the appearance and feel of post-burn scars.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

Scalp cooling and minoxidil can help manage hair loss after chemotherapy.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

Prevent persistent hair loss after chemotherapy with scalp cooling and early minoxidil use.

The new hydrogel with curcumin speeds up wound healing safely and effectively.

PRP may increase hair density but doesn't improve quality of life in breast cancer survivors with hair loss.

Some pediatric Ewing's sarcoma patients may experience permanent hair loss after chemotherapy, and treatments might not fully restore hair.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

A woman regrew her hair after receiving injections of special cell-derived vesicles.

Topical minoxidil may help regrow hair after permanent hair loss from chemotherapy.

Age, diabetes, and cardiogenic shock at PCI are key factors linked to in-hospital death in STEMI patients with hypertension.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Asian women with breast cancer experience the highest rates of long-term hair loss and related distress after chemotherapy.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Improved collaboration and education between dermatologists and oncologists can enhance care for chemotherapy-related hair loss.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

Different cells affect hair follicle blood vessels, endothelial cells react differently to inflammation and oxidized fats, and prasugrel better protects heart vessels during a procedure than clopidogrel.

Providing housing and case management reduces hospital visits for chronically ill homeless adults.

Chemotherapy caused a woman's permanent hair loss and early menopause.